` Comparison: HUMA, PNEXF - Alpha Spread

HUMA
vs
PNEXF

Over the past 12 months, HUMA has underperformed PNEXF, delivering a return of -70% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
HUMA
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

HUMA Intrinsic Value
3.04 USD
Undervaluation 58%
Intrinsic Value
Price
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Humacyte Inc
NASDAQ:HUMA
1.28 USD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
HUMA, PNEXF

HUMA
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Humacyte Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
HUMA, PNEXF

HUMA
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Humacyte Inc
NASDAQ:HUMA
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

HUMA
60.5%
PNEXF
0%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

Operating Margin

HUMA
-6 702.8%
PNEXF
-17 526.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

Net Margin

HUMA
-2 357%
PNEXF
-21 040%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

FCF Margin

HUMA
-6 743.9%
PNEXF
-15 953.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

ROE

HUMA
107.7%
PNEXF
114.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

ROA

HUMA
-35.9%
PNEXF
-391.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

ROIC

HUMA
-140.4%
PNEXF
3 092.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

ROCE

HUMA
-131.7%
PNEXF
275.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Humacyte Inc
Pharnext SCA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
HUMA, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HUMA, PNEXF

Loading
HUMA
PNEXF
Difference
www.alphaspread.com

Performance By Year
HUMA, PNEXF

Loading
HUMA
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare HUMA to other stocks
Unlock Full Access to Alpha Spread
Create Free Account